Training Seminars by Cambridge Healthtech Institute

Cambridge Healthtech Institute Training Seminars offer real-life case studies, problems encountered, and solutions applied, along with extensive coverage of the academic theory and background. Each training seminar offers a mix of formal lecture and interactive discussions and activities to maximize the learning experience. These training seminars are led by experienced instructors who will focus on content applicable to your current research and provide important guidance for those new to their fields.

Monday, 18 November Tuesday, 19 November
Day 1

13:3018:20 Training Seminars in Session

18:2019:30 Welcome Reception

Day 2

8:3018:30 Training Seminars in Session

12:45 Lunch Provided

Refreshment breaks and exhibit hall viewing hours also provided.

TS6A: Antibody Deep Sequencing and Single Cell Analysis

Instructor:

Brandon DeKosky, PhD, Assistant Professor, Department of Chemical Engineering, Department of Pharmaceutical Chemistry, Kansas Vaccine Institute, The University of Kansas

In this training seminar, participants will learn about recently developed methods for Next-Generation Sequencing (NGS) and single-cell analysis of antibody repertoires. Part 1 will provide an introduction to antibody repertoires, including genetic background, generation of diversity, and sequencing technologies. Part 2 will incorporate an introduction and hands-on session on computational tools for analyzing antibody repertoire NGS data. We will focus on pre-processing, analysis, and visualization of data, along with presentation of existing bioinformatics pipelines available. Part 3 will focus on an overview of the development of newer methods in single-cell analysis of antibody immune responses. The course will be interactive with case studies, and participants will be able to download data and examples. Please bring your computer.

TS7A: Intro to Bispecifics: History, Engineering, and Applications

Instructors:

Regis Cebe, MSc, Scientific Technical Leader, Novartis Biologic Center, NIBR, Novartis Pharma AG, Switzerland

Rakesh Dixit, PhD, DABT, President & CEO, Bionavigen

Intro to Bispecifics will be organized as an informative and practical guide to get up to speed on critical aspects of bispecific antibody therapeutics. Topics will include historical successes, failures, and lessons learned. Specific practical instruction will span mechanisms of action, engineering, developability, regulatory considerations, and translational guidelines. Perspectives on ideal implementation of bispecifics as targeted and immunomodulatory approaches will be discussed.

Wednesday, 20 November and Thursday, 21 November
Day 1

8:3017:45 Training Seminars in Session

12:45 Lunch Provided

17:4518:45 Networking Reception

18:4519:45 Problem Solving Breakout Discussions

Day 2

8:3012:45 Training Seminars in Session

Refreshment breaks and exhibit hall viewing hours also provided.

TS6B: Genome Editing with CRISPR: Toward Novel Research, Translational and Clinical Applications

Instructor:

Serguei V. Kozlov, PhD, MBA, PMP, Principal Scientist/PM, Team Leader PTO, Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research (NCI)

This rigorous day-and-a-half program compiled for specialists interested in applying genome editing technologies for both basic and translational research will comprehensively review the state-of-the-art information on gene editing strategies and applications in various areas, such as disease modelling, drug discovery, and development. Beginning from introductory level basic technology aspects, key molecular features, strengths, and shortcomings of CRISPR/Cas9 systems, the instructor will advance towards sharing in-depth knowledge related to virtually all facets of present-day genome editing applications, such as constructing of cell culture-based experimental platforms, engineering disease models for in vivo research supporting preclinical drug development workflows, rational design and functional screening of sgRNA libraries, application of CRISPR/Cas9 technology for diagnostic and therapeutic purposes, and many others.

TS7B: Rational Approaches to Biologics Formulation and Delivery

Instructor:

Christina Vessely, PhD, Senior Consultant, CMC, Analytical and Formulation Development, Biologics Consulting

This course is intended to give participants an understanding of the basic principles of biologics formulation development, with an emphasis on maintaining long-term product stability. Participants should expect to come away with a better understanding of biochemical and biophysical properties of proteins and peptides, and how excipients and other strategies can be used to mitigate degradation. Formulation development discussions will cover both liquid and lyophilized dosage forms. The focus of the session will be on maximizing efficiency during formulation development, with an eye on regulatory compliance throughout the product development lifecycle. As such, following the introduction to formulation development, we will cover more complex formulation development topics, including strategies for the formulation of low solubility APIs, advice for the selection of container/closure systems and drug delivery devices, as well as the studies that must be performed to demonstrate the compatibility of those materials with the product.

* The program is subject to change without notice, due to unforeseen reason.

Choose your language
Japanese
Traditional Chinese
Simplified Chinese
Korean


Update History
2019/08/09
Sponsor updated
2019/08/06
Agenda updated
2019/06/27
Agenda,Sponsor updated